Hepatitis E virus (HEV) infection which may become fulminant, especially in elderly people is more common than previously recognized in develop countries. Here we report successful living-donor liver transplantation (LDLT) in a case of acute liver failure due to HEV. A 63-year-old Japanese man with no previous history of liver disease was admitted for severe acute hepatitis. Detection of anti-HEV immunoglobulin A established a diagnosis of this virus-related liver failure. The patient suffered from hepatic encephalopathy 10 days after symptom onset and underwent LDLT. The patient had an uneventful course. The HEV RNA showed spontaneous negative conversion 10 weeks after LDLT. LDLT led to a successful outcome in a patient with acute liver failure due to HEV infection and regular testing for HEV RNA should be performed until HEV RNA is undetectable.
Introduction
Hepatitis E virus (HEV) infection in developed countries is more common than previously recognized. Testing for this virus is, therefore, recommended for patients with acute hepatitis that cannot be explained by other causes. Hepatitis E may become fulminant, especially in elderly people. 1 The indication for liver transplantation is not established, and the effect of immunosuppression in Hepatitis E infection is not well understood.
Presenting Concern
The patient was a 63-year-old Japanese man. He presented with fatigue and cough and was taking common cold medications with no effect. He had no history of liver disease but had eaten uncooked deer and boar meat approximately 4 and 3 months earlier, respectively. A few days later, he developed nausea and anorexia. The patient consent was obtained.
Clinical Findings
Liver function test results included total bilirubin 5.8 mg/dL, alanine aminotransferase 6469 U/L, and a prothrombin time-international normalized ratio of 3.83. He was diagnosed with acute liver failure and hospitalized.
Detection of anti-HEV immunoglobulin A established a diagnosis of this virus-related liver failure. The test revealed HEV genotype 3. Hepatitis E and drug-induced liver injury were suspected based on the patient's history. Five days after the onset of encephalopathy, he developed a grade 3 hepatic coma.
Outcome
Living donor liver transplantation was performed with a right lobe graft of his son. Histology of the explanted liver showed massive necrosis without fibrosis. The patient had an uneventful course and was discharged from the hospital on postoperative day 43. Now 8 months posttransplant, his graft function is normal. The HEV serologic tests followed the course of a transient infection (Figure 1 ). The HEV RNA has now remained negative.
Discussion
Only 5 reported patients with HEV genotype 3-associated acute liver failure have received rescue transplantation, including the present case. Four of the 5 who survived the surgery had successful outcomes 2 and the 3 previously reported patients underwent deceased donor liver transplantation. Therefore, this is the first surviving case of living donor transplantation for HEV-related liver failure. The outcomes of our patient demonstrate the feasibility of living donation as a treatment option for such patients.
In Japan, genotype 3 HEV is more prevalent than genotype 4 HEV and is related to sporadic autochthonous cases in developed countries. The incubation period of the present case was about 3 months, which is longer than previously reported of 3 to 8 weeks. 3 The course of the HEV-RNA titer after transplantation is not yet clarified. In our case, it took 2.5 months for HEV RNA to become undetectable, which suggests that an immunosuppressive state led to persistent HEV RNA. Our patient did not take ribavirin after transplantation, but the HEV titer later spontaneously reduced. Given that our patient was HEV RNA positive when transplanted, ribavirin should also have been administered after transplantation to avoid chronic HEV infection of the graft. 4, 5 In 1 study in a large cohort of solid organ transplant recipients, HEV became chronic in approximately 66%. 3 Regular testing for HEV RNA should be performed until HEV RNA is undetectable.
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